NASDAQ:MENS Jyong Biotech (MENS) Stock Price, News & Analysis $1.86 +0.06 (+3.33%) Closing price 11/18/2026 04:00 PM EasternExtended Trading$1.86 +0.00 (+0.27%) As of 11/18/2026 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About Jyong Biotech Stock (NASDAQ:MENS) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Jyong Biotech alerts:Sign Up Key Stats Today's Range$1.58▼$1.9150-Day Range$1.65▼$2.3852-Week Range$1.43▼$38.88Volume69,523 shsAverage Volume39,953 shsMarket Capitalization$141.42 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingSell Company Overview Jyong Biotech is a clinical-stage biopharmaceutical company based in Taiwan that develops treatments for urological diseases. Its research focuses on botanical drug candidates, including therapies for conditions affecting the prostate and urinary system. The company’s pipeline includes MCS-2, a botanical drug candidate being developed for benign prostatic hyperplasia, a noncancerous enlargement of the prostate. Jyong Biotech is also developing other candidates for urological conditions. Jyong Biotech was established in Taiwan and conducts drug development activities there. Its focus is on advancing its pipeline through clinical development; its candidates are investigational and are not established treatments.AI Generated. May Contain Errors. Read More Receive MENS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Jyong Biotech and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. MENS Stock News HeadlinesJyong Biotech to Host Two-Day Investor Events in Silicon Valley and Irvine, CaliforniaOctober 21, 2026 | globenewswire.comJyong Biotech Ltd. Plans to Establish Potential New Manufacturing Facility and U.S. Operations Center in TexasOctober 15, 2026 | marketscreener.comMMy $247 scanner for $7Bill Poulos is cutting the price of his $247 Instant Scanner to $7 for Black Friday. It's a one-time payment that covers a full year, with no subscription and no re-bills. Every night after the close, the scanner screens nearly a thousand of America's biggest stocks. It returns a short list of qualifying setups with the exact buy price next to each one. There's nothing to install. If you decide it's not for you, you get the $7 back and keep the scanner for the year. | Profits Run (Ad)Jyong Biotech Targets BPH/LUTS Market With Proposed U.S. Manufacturing FacilityOctober 15, 2026 | rttnews.comJyong Biotech Plans Potential Texas Manufacturing Facility and U.S. Operations CenterOctober 15, 2026 | quiverquant.comQJyong Biotech Announces Proposed Texas Facility to Support Potential Commercialization of Its Drug CandidatesOctober 15, 2026 | globenewswire.comJyong Biotech Announces Participation in StockFan Virtual Investor Non-Deal RoadshowSeptember 3, 2026 | globenewswire.comJyong Biotech Ltd. Ordinary Shares (MENS)July 29, 2026 | nasdaq.comSee More Headlines MENS Stock Analysis - Frequently Asked Questions How have MENS shares performed this year? Jyong Biotech's stock was trading at $3.95 at the beginning of 2026. Since then, MENS stock has decreased by 52.9% and is now trading at $1.86. When did Jyong Biotech IPO? Jyong Biotech (MENS) raised $21 million in an IPO on Tuesday, June 17th 2025. The company issued 2,666,667 shares at $7.50-$8.50 per share. Who are Jyong Biotech's major shareholders? Top institutional shareholders of Jyong Biotech include StoneX Group Inc. (0.02%). How do I buy shares of Jyong Biotech? Shares of MENS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Today11/19/2026Fiscal Year End12/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Pharmaceuticals Sub-IndustryPharmaceuticals Current SymbolNASDAQ:MENS Previous SymbolNASDAQ:MENS CIK1954488 Webwww.jyongbio.com Phone(8862) 27325205FaxN/AEmployees27Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value($0.33) per share Price / Book-5.64Miscellaneous Outstanding Shares76,030,000Free FloatN/AMarket Cap$141.42 million OptionableOptionable Beta2.52 The 7 Best High-Yield Dividend Stocks for 2027Looking for higher dividend income in 2027? Discover seven high-yield dividend stocks with attractive payouts, proven dividend histories and growth potential.Get This Free Report This page (NASDAQ:MENS) was last updated on 11/18/2026 by MarketBeat.com Staff. From Our PartnersYour $7 scanner is waitingThe Instant Scanner is $7 in Bill Poulos's Black Friday sale. Every night it delivers a list showing which sto...Profits Run | SponsoredPentagon magnet restrictions take effect January 1, 2027A NASDAQ-listed company has signed a term sheet outlining a potential 75-year agreement with the U.S. Army. It...OilPrice | SponsoredTop Trader Reveals Stunning Black Friday DealOthers paid $500 for the Snapback Indicator. This Black Friday, it's available for just $7. Base Camp Tradi...Base Camp Trading | SponsoredToday's free pick (on me)Elon Musk doesn't own the chip inside every Tesla, Starlink dish, and AI satellite - he licenses it from one l...Behind the Markets | SponsoredMy public warning after 55 years of watching the marketsDr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each war...Weiss Ratings | SponsoredThe investigation Porter spent tens of thousands to documentPorter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experi...Porter & Company | Sponsored432 miles southeast of Washington, DC…Spruce Pine, North Carolina, a town of just over 2,000 people, has supplied a material to every major chip mak...Wall Street Watchdogs | SponsoredBeyond NVDA: The World’s Next #1 Company?This small-cap trades in an overlooked corner of the market, with a market cap more than 600X smaller than Nvi...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Jyong Biotech Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Jyong Biotech With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.